Participant characteristics
| Young | Patient | |
| Age (years) | 25 ± 4 | 60 ± 8 |
| Age range | 21–35 | 48–73 |
| Height (m) | 1.80 ± 0.08 | 1.69 ± 0.09 |
| Weight (kg) | 78 ± 13 | 83 ± 21 |
| BMI (U) | 24 ± 3 | 29 ± 7 |
| SBP (mm HG) | 126 ± 14 | 144 ± 18 |
| DBP (mm HG) | 74 ± 10 | 76 ± 9 |
| MAP (mm HG) | 93 ± 11 | 100 ± 11 |
| Glucose (mmol/L) | 5.85 ± 0.76 | |
| HDL (mmol/L) | 1.54 ± 0.42 | |
| LDL (mmol/L) | 3.29 ± 0.78 | |
| Total cholesterol (mmol/L) | 5.39 ± 0.92 | |
| Triglycerides (mmol/L) | 1.29 ± 0.60 | |
| hsCRP (mg/L) | 2.83 ± 3.90 | |
| hsCRP Range (mg/L) | 0.3–18.6 |
| Young | Patient | |
| Age (years) | 25 ± 4 | 60 ± 8 |
| Age range | 21–35 | 48–73 |
| Height (m) | 1.80 ± 0.08 | 1.69 ± 0.09 |
| Weight (kg) | 78 ± 13 | 83 ± 21 |
| BMI (U) | 24 ± 3 | 29 ± 7 |
| SBP (mm HG) | 126 ± 14 | 144 ± 18 |
| DBP (mm HG) | 74 ± 10 | 76 ± 9 |
| MAP (mm HG) | 93 ± 11 | 100 ± 11 |
| Glucose (mmol/L) | 5.85 ± 0.76 | |
| HDL (mmol/L) | 1.54 ± 0.42 | |
| LDL (mmol/L) | 3.29 ± 0.78 | |
| Total cholesterol (mmol/L) | 5.39 ± 0.92 | |
| Triglycerides (mmol/L) | 1.29 ± 0.60 | |
| hsCRP (mg/L) | 2.83 ± 3.90 | |
| hsCRP Range (mg/L) | 0.3–18.6 |
Values are mean ± SD. Blood samples were not assessed for the young group as their clinical status was not in question. Normal ranges: glucose, 3.6–6.0 mmol/L; HDL, (male) ≥1.0 mmol/L and (female) ≥ 1.3 mmol/L; LDL, <2.6 mmol/L; total cholesterol, <5.2 mmol/L; triglycerides, <2.3 mmol/L; hsCRP, 1.0–1.3 mg/L. There were 8 males and 3 females in the young group and 21 males and 24 females in the patient group. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; hsCRP, high sensitivity C-reactive protein.